CYTK – cytokinetics, incorporated (US:NASDAQ)
Stock Stats
News
CareMed Has Been Selected as a National Specialty Pharmacy Provider for MYQORZO™ (aficamten) [Yahoo! Finance]
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Cytokinetics (NASDAQ:CYTK) was given a new $90.00 price target on by analysts at Morgan Stanley.
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your Behalf
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment, Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
Form 4 CYTOKINETICS INC For: Jan 15 Filed by: Wysenski Nancy
Form 4 CYTOKINETICS INC For: Jan 15 Filed by: WIERENGA WENDELL
Form 4 CYTOKINETICS INC For: Jan 15 Filed by: Kaye Edward M. MD
Form 4 CYTOKINETICS INC For: Jan 15 Filed by: HENDERSON JOHN T
Form 4 CYTOKINETICS INC For: Jan 15 Filed by: Harrington Robert Arthur
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.